In conclusion , intravenous administration of COMPOUND_XXX at doses of 0.2 , 0.6 and 1.2 mg / kg for 13 weeks using a once weekly dosing schedule was associated with compound - related clinical signs , decreases in basophil , eosinophil and lymphocyte counts and increases in fibrinogen at doses ≥ 0.2 mg / kg .
In conclusion , intravenous administration of COMPOUND_XXX at doses of 0.2 , 0.6 and 1.2 mg / kg for 13 weeks using a once weekly dosing schedule was associated with compound - related clinical signs , decreases in basophil , eosinophil and lymphocyte counts and increases in fibrinogen at doses ≥ 0.2 mg / kg .
O O O O O O O O O O B-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE O O O O O O O O O O O O O O O O O O B-MANIFESTATION_FINDING O B-STUDY_TESTCD O B-STUDY_TESTCD O B-STUDY_TESTCD I-STUDY_TESTCD O B-MANIFESTATION_FINDING O B-STUDY_TESTCD O O O B-DOSE I-DOSE I-DOSE I-DOSE O